Modulation of glycogen synthase kinase-3β following TRAIL combinatorial treatment in cancer cells

Glycogen Synthase Kinase-3β (GSK3β) is a serine/threonine kinase, known to regulate various cellular processes including proliferation, differentiation, survival, apoptosis as well as TRAIL-resistance. Thus pathways that can modulate GSK3β axis are important targets for cancer drug development. Our...

Descripción completa

Detalles Bibliográficos
Autores principales: Santha, Sreevidya, Davaakhuu, Gantulga, Basu, Aninda, Ke, Rong, Das, Subhasis, Rana, Ajay, Rana, Basabi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341845/
https://www.ncbi.nlm.nih.gov/pubmed/27602497
http://dx.doi.org/10.18632/oncotarget.11834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341845/
https://www.ncbi.nlm.nih.gov/pubmed/27602497
http://dx.doi.org/10.18632/oncotarget.11834

Ejemplares similares